Sources

The six peptides, and how to tell a pharmacy vial from a website vial

Dr. Rick Pescatore
Rick Pescatore, DO
Emergency physician. October 17, 2026

Everything I said in this morning's video, where each claim came from, and the one question to ask before your next order. I am not telling you these peptides work. I am telling you what changed, and how to tell a pharmacy vial from a website vial.

6peptides the FDA's advisory panel voted to let pharmacies make
8 to 6the vote on BPC-157, after the FDA's own scientists said no
3published human studies of BPC-157, fewer than 30 people in all, none of them a controlled trial

What a peptide is

“Insulin's a peptide. So is Ozempic.”

A peptide is a short chain of amino acids, the building blocks of protein. Your body uses peptides as messengers between cells. Insulin was the first one anyone put in a syringe, in 1922. Semaglutide, sold as Ozempic and Wegovy, is a peptide built to copy a gut hormone. More than 80 peptide drugs have been approved worldwide. The word covers Nobel-prize medicine and it covers vials sold on the internet. Knowing which kind you are holding is the whole point of this page.

The six

“The six the FDA just moved on are a different kind.”

On July 23 and 24, 2026, the FDA's Pharmacy Compounding Advisory Committee voted on seven peptides. Six passed. BPC-157, KPV and TB-500 each passed 8 to 6 with one abstention. MOTS-c, Epitalon and Semax passed by wider margins. Emideltide, also called DSIP, failed 6 to 7. A second meeting, expected by February 2027, will take up GHK-Cu, LL-37, Dihexa, Melanotan II and PEG-MGF.

  • BPC-157. Promoted online for injury and gut repair. The most-bought of the six, and the one the rest of this page is about.
  • KPV. A three-amino-acid fragment of a hormone called alpha-MSH, studied in animal models of gut inflammation.
  • TB-500. A fragment of thymosin beta-4, promoted for tissue repair; the animal data is for the parent protein.
  • MOTS-c. A peptide encoded by mitochondrial DNA, studied in animals for metabolism and exercise capacity.
  • Epitalon. A four-amino-acid synthetic peptide from Russian research on aging; the human work is decades old and small.
  • Semax. A nasal peptide sold as a prescription drug in Russia for stroke and cognition. Of the six, it is the only one with a drug license anywhere.

The committee's votes are advice. The Secretary of Health and Human Services decides. The policy sent to the White House on October 14 has not been published, so nobody outside the government has seen the final list. Two people familiar with it told the Associated Press it includes BPC-157.

BPC-157: stomach juice, rats, and a handful of people

“The famous one, BPC-157, was found in human stomach juice.”

In 1993 a research group in Zagreb, Croatia, reported a protein in human gastric juice they named BPC, for body protection compound, and a 15-amino-acid piece of it they called BPC 157. The synthetic version sold today is that 15-amino-acid fragment.

“Nearly all the data we have comes from rat studies and a small handful of tiny human ones.”

The same Zagreb group has published well over a hundred animal studies on BPC-157 across three decades, and its own reviews count more than 150. A 2025 systematic review of the orthopedic and sports-medicine literature found 35 animal studies and one uncontrolled human chart review, and no completed controlled trial in people. As of 2026, the published human record is three small studies, fewer than 30 people in total: a retrospective report of 12 people with knee pain, a small study in interstitial cystitis, and a two-person safety study. The FDA's own briefing document for the July meeting reaches the same conclusion.

What happened in 2023, and what happened next

“In 2023, the FDA told pharmacies to stop making it.”

In September 2023 the FDA put BPC-157 and several other peptides in what it calls Category 2: substances with significant safety concerns that compounding pharmacies may not use while the agency reviews them. In April 2026 the FDA took 12 peptides back off that list, which stopped short of letting pharmacies make them.

“Nobody stopped. People bought it from websites. Vials stamped ‘not for human use,’ made overseas, mostly in China, shipped to your door, and injected on a dose from a calculator on the same website.”

That description is the FDA's, not mine. On August 24, 2026, the agency sent warning letters to five online peptide sellers. It wrote that despite labels saying "for research use only" and "not for human or veterinary use," the websites sold bacteriostatic water, mixing instructions, injection guides and dose calculators alongside the vials, which together establish that the products are intended as drugs for people. "Made in China and other countries" is the Health Secretary's own description of the gray market he says the new policy is meant to replace.

June, July, and this week

“In June, the FDA's own scientists said no. A month later, an advisory panel overruled them, and this week it went to the White House.”

The FDA's staff review, released ahead of the July meeting, recommended against adding any of the seven peptides, citing safety concerns and limited human data. The outside committee voted the other way on six of them on July 23 and 24. On October 14, 2026, HHS and the FDA sent an "Interim Access Policy for Compounding Using Certain Peptides" to the White House Office of Management and Budget for review. The agency's statement said the action "begins to restore regulated access and will immediately begin shifting demand away from the black market."

What the policy is expected to do, based on how these policies usually work: tell state-licensed compounding pharmacies that the FDA will not enforce against them for making certain peptides for individual patients with a prescription. What it does not do: approve any product, cover "research use only" websites or supplements, bind state pharmacy boards, or promise anything permanent. It can be narrowed or withdrawn without a formal process. There is no fixed date for it to take effect.

Why I called it harm reduction

“When you can't stop something, you make it safer. That's why Narcan is on the shelf at CVS.”

Harm reduction is the public health practice of meeting people where they are and lowering the risk of what they are already doing, instead of pretending they will stop. The FDA approved Narcan nasal spray for sale without a prescription in March 2023, and it reached store shelves that September. Nobody who put it there approved of overdoses. The peptide policy is the same shape: not an endorsement, a decision about which of two existing markets people should be buying from.

How to tell a pharmacy vial from a website vial

“Before the next order, ask one question. Who made this?”

If you use these, this is the part of the page to keep. A compounded prescription is made under rules. The website vial is not. Here is what the rules look like from your side of the counter.

  • A real prescription. Written by a clinician who evaluated you, not a menu where you pick the product and a prescriber signs off. In September 2026 the FDA warned a compounder specifically about prescriptions "generated through preselected options on third-party telehealth platforms."
  • A licensed pharmacy you can look up. The label should carry the pharmacy's name and address, your name, the drug and strength, a prescription or lot number, and a beyond-use date. The pharmacy should be licensed by your state's board of pharmacy, and you can check.
  • An ingredient with paperwork. Compounding pharmacies have to buy the raw peptide from an FDA-registered facility and keep a certificate of analysis for it. Ask the pharmacist where the ingredient came from. A real pharmacy can answer in one sentence.
  • A pharmacist you can call. With a phone number that a person answers.

And the website tells on itself. "Research use only" or "not for human use" on the label. A dose calculator or mixing guide next to the buy button. Bacteriostatic water sold as a bundle. Payment by crypto or Zelle only. A warehouse return address instead of a pharmacy. Any one of those is the FDA's own list of red flags, and it means nobody checked what is in the vial, how strong it is, or whether it is sterile.

Two things stay true at the same time. Nobody has shown that these peptides work in people. And a pharmacy vial still beats a mystery one. If you are using a website vial and you get a fever, a hot swollen injection site, hives or trouble breathing, that is an emergency department visit, and bring the vial with you.

For clinicians

  • Ask about peptides the way you ask about supplements, and ask where they came from. Patients using "research use only" product are injecting an unverified substance of unknown sterility and potency; injection-site cellulitis and abscess are the presenting complaints to expect, and the differential should include contaminant and endotoxin reactions.
  • BPC-157 is reported in rodent work to act through VEGFR2 and nitric oxide pathways. There is no human safety data in patients with active or recent malignancy, and no drug-interaction data at all. Document the exposure.
  • For athletes: BPC-157 has been on the WADA prohibited list under S0 (non-approved substances) since 2022.
  • If the interim policy is finalized, expect prescription requests. A compounded peptide under 503A still requires your independent judgment that the patient needs it; the FDA's September 2026 letter about telehealth-generated prescriptions is the reference point.

Not medical advice for your situation. I don't sell peptides and no peptide company paid for this page. If you're worried about a specific symptom, get seen.

Know someone this is for? Send them this page.

Every number on this page links to where it came from. If I got one wrong, tell me and I'll correct it here.

Dr. Rick Pescatore in a white coat

Rick Pescatore, DO

I'm an emergency physician, the editor-in-chief of Emergency Medicine News, and a former chief physician for Delaware's Division of Public Health. I founded BellyMD to work on the gut-brain problems medicine tends to wave off.

Earlier pages

The flu mutated: who it's slipping past, why, and what to do this weekThe Vegas mpox case: what the CDC said, what it means, and when to get swabbedTherapy in pregnancy and the baby's brain: the trial, the scan, and what to ask forThe lemon smell: what Purdue measured, and how to read the label